---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291192058.md"
description: "During Monday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Gain Therapeutics (GANX) up 20.2%, BNB Plus (BNBX) up 9.78%, and Baird Medical Investment (BDMD) up 9.64%. Conversely, losers featured Nuvectis Pharma (NVCT) down 19.4%, Decoy Therapeutics (DCOY) down 14.5%, and electroCore (ECOR) down 9.93%. The data covers price movements and market caps for these specific equities."
datetime: "2026-06-29T21:05:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291192058.md)
  - [en](https://longbridge.com/en/news/291192058.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291192058.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **Gain Therapeutics** (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market session. The market value of their outstanding shares is at $74.6 million.
-   **BNB Plus** (NASDAQ:BNBX) stock rose 9.78% to $0.38. The market value of their outstanding shares is at $2.7 million.
-   **Baird Medical Investment** (NASDAQ:BDMD) shares rose 9.64% to $1.25. The market value of their outstanding shares is at $33.9 million.
-   **Curanex Pharmaceuticals** (NASDAQ:CURX) shares rose 9.02% to $0.29. The market value of their outstanding shares is at $7.5 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock moved upwards by 8.86% to $2.21. The company's market cap stands at $10.7 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares increased by 8.35% to $0.75. The company's market cap stands at $33.8 million.

### Losers

-   **Nuvectis Pharma** (NASDAQ:NVCT) shares declined by 19.4% to $23.0 during Monday's after-market session. The company's market cap stands at $721.2 million.
-   **Decoy Therapeutics** (NASDAQ:DCOY) stock decreased by 14.5% to $8.2. The market value of their outstanding shares is at $2.9 million.
-   **electroCore** (NASDAQ:ECOR) stock fell 9.93% to $7.31. The market value of their outstanding shares is at $65.0 million.
-   **Jyong Biotech** (NASDAQ:MENS) shares decreased by 9.1% to $2.0. The company's market cap stands at $142.9 million.
-   **Trinity Biotech** (NASDAQ:TRIB) stock declined by 9.08% to $0.38. The market value of their outstanding shares is at $7.3 million.
-   **Jin Medical International** (NASDAQ:ZJYL) shares fell 8.53% to $2.04. The company's market cap stands at $17.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [NVCT.US](https://longbridge.com/en/quote/NVCT.US.md)
- [ECOR.US](https://longbridge.com/en/quote/ECOR.US.md)
- [BDMD.US](https://longbridge.com/en/quote/BDMD.US.md)
- [BNBX.US](https://longbridge.com/en/quote/BNBX.US.md)
- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [GANX.US](https://longbridge.com/en/quote/GANX.US.md)
- [CURX.US](https://longbridge.com/en/quote/CURX.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [MENS.US](https://longbridge.com/en/quote/MENS.US.md)
- [TRIB.US](https://longbridge.com/en/quote/TRIB.US.md)
- [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md)

## Related News & Research

- [Baird Medical’s BD-GT microwave ablation system wins Pakistan DRAP registration](https://longbridge.com/en/news/296491588.md)
- [Gain Therapeutics joins H.C. Wainwright Global Investment Conference for investor meetings](https://longbridge.com/en/news/296901905.md)
- [Nuvectis Pharma sets up $200 million at-the-market equity program with Jefferies](https://longbridge.com/en/news/296650648.md)
- [HealthEquity (NASDAQ:HQY) Issues FY 2027 Earnings Guidance](https://longbridge.com/en/news/297190021.md)
- [Congresswoman Vs. Hedge Fund: One Throws in the Towel on Peloton Stock, the Other is Buying](https://longbridge.com/en/news/296831168.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**